20
Participants
Start Date
June 1, 2017
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2027
Tumor samples from patients treated with TTFields at initial diagnosis.
Pathological assessment of tumor cellularity, apoptosis, and quantitative histo-morphometry of residual tumor cells will be performed. Each metric will be statistically compared between groups.
Tumor samples from patients treated with TTFields at tumor recurrence.
Pathological assessment of tumor cellularity, apoptosis, and quantitative histo-morphometry of residual tumor cells will be performed. Each metric will be statistically compared between groups.
RECRUITING
Froedtert & the Medical College of Wisconsin, Milwaukee
Medical College of Wisconsin
OTHER